Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

ART and tuberculosis: the final nail in nevirapine's coffin?

Maartens G.

Lancet Infect Dis. 2013 Apr;13(4):278-9. doi: 10.1016/S1473-3099(13)70049-5. Epub 2013 Feb 20. No abstract available.

PMID:
23433591
2.

Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial.

Bonnet M, Bhatt N, Baudin E, Silva C, Michon C, Taburet AM, Ciaffi L, Sobry A, Bastos R, Nunes E, Rouzioux C, Jani I, Calmy A; CARINEMO study group.

Lancet Infect Dis. 2013 Apr;13(4):303-12. doi: 10.1016/S1473-3099(13)70007-0. Epub 2013 Feb 20.

PMID:
23433590
3.

Co-administration of rifampin and nevirapine in HIV-infected patients with tuberculosis.

Oliva J, Moreno S, Sanz J, Ribera E, Molina JA, Rubio R, Casas E, MariƱo A.

AIDS. 2003 Mar 7;17(4):637-8. No abstract available.

PMID:
12598789
4.

Nevirapine or efavirenz for tuberculosis and HIV coinfected patients: exposure and virological failure relationship.

Bhatt NB, Baudin E, Meggi B, da Silva C, Barrail-Tran A, Furlan V, Grinsztejn B, Bonnet M, Taburet AM; ANRS 12146/12214-CARINEMO Study Group.

J Antimicrob Chemother. 2015 Jan;70(1):225-32. doi: 10.1093/jac/dku348. Epub 2014 Sep 18.

5.

Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study.

Manosuthi W, Tantanathip P, Chimsuntorn S, Eampokarap B, Thongyen S, Nilkamhang S, Sungkanuparph S.

Int J Infect Dis. 2010 Nov;14(11):e1013-7. doi: 10.1016/j.ijid.2010.06.016. Epub 2010 Sep 28.

6.

Efavirenz and nevirapine interactions with rifampicin: resolving the dilemmas?

Lalloo UG.

Clin Infect Dis. 2009 Jun 15;48(12):1760-2. doi: 10.1086/599115. No abstract available.

7.

Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin.

Manosuthi W, Sungkanuparph S, Thakkinstian A, Rattanasiri S, Chaovavanich A, Prasithsirikul W, Likanonsakul S, Ruxrungtham K.

Clin Infect Dis. 2006 Jul 15;43(2):253-5. Epub 2006 Jun 12.

8.

Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis.

Manosuthi W, Ruxrungtham K, Likanonsakul S, Prasithsirikul W, Inthong Y, Phoorisri T, Sungkanuparph S.

Clin Infect Dis. 2007 Jan 1;44(1):141-4. Epub 2006 Nov 21.

9.

Reflections on the time of initiating ART in HIV-TB patients.

Soman R, Patel A.

J Assoc Physicians India. 2012 Sep;60:70. No abstract available.

PMID:
23547420
10.

HIV and tuberculosis: think local, act global.

Street A.

Intern Med J. 2004 Apr;34(4):150-2. No abstract available.

PMID:
15086693
11.

Management challenges in tuberculosis and HIV.

Meintjes G.

S Afr Med J. 2014 Dec;104(12):885. No abstract available.

PMID:
26042272
12.

Safety and efficacy of nevirapine- and efavirenz-based antiretroviral treatment in adults treated for TB-HIV co-infection in Botswana.

Shipton LK, Wester CW, Stock S, Ndwapi N, Gaolathe T, Thior I, Avalos A, Moffat HJ, Mboya JJ, Widenfelt E, Essex M, Hughes MD, Shapiro RL.

Int J Tuberc Lung Dis. 2009 Mar;13(3):360-6.

13.
14.

Funding. Experts look for more to fight TB, HIV/AIDS coinfection.

[No authors listed]

AIDS Policy Law. 2009 Sep;24(10):3. No abstract available.

PMID:
19827208
15.

Anti-HIV agents. Once-daily anti-HIV therapy in people co-infected with TB.

[No authors listed]

TreatmentUpdate. 2004 Apr-May;16(3):4-5. No abstract available.

PMID:
17219607
16.

Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis.

Cohen K, van Cutsem G, Boulle A, McIlleron H, Goemaere E, Smith PJ, Maartens G.

J Antimicrob Chemother. 2008 Feb;61(2):389-93. Epub 2007 Dec 19.

17.

Highly active antiretroviral therapy for patients with tuberculosis: the solution or the problem?

Boix V, Merino E, Portilla J.

AIDS. 2002 Jul 5;16(10):1436-7. No abstract available.

PMID:
12131228
18.

Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi?

Zachariah R, Teck R, Ascurra O, Gomani P, Manzi M, Humblet P, Nunn P, Salaniponi FM, Harries AD.

Int J Tuberc Lung Dis. 2005 Mar;9(3):238-47. Review.

PMID:
15786885
19.

Report from the 12th Retrovirus Conference. Tuberculosis.

Friedland GH.

AIDS Clin Care. 2005 Apr;17(4):40-1. No abstract available.

PMID:
15875315
20.

Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians.

van Oosterhout JJ, Kumwenda JJ, Beadsworth M, Mateyu G, Longwe T, Burger DM, Zijlstra EE.

Antivir Ther. 2007;12(4):515-21.

PMID:
17668560
Items per page

Supplemental Content

Write to the Help Desk